Sanofi, Regeneron shares pop more than 6% after data shows asthma drug Dupixent may also treat COPD
March 23, 2023 at 14:31 PM EDT
Sanofi and Regeneron unveiled data on their jointly developed drug for a difficult-to-treat chronic lung disorder that analysts say "exceeded expectations."
